文献速递脊髓损伤康复疼痛康复

疼痛干扰在脊髓损伤者疼痛强度与可能重性抑郁间的中介效应

Mediating Effects of Pain Interference on the Relationships Between Pain Intensity and Probable Major Depression Among Participants With Spinal Cord Injury.
PubMed 文献 · Arch Phys Med Rehabil · 2021-05-17

该横断面研究纳入4670例病程至少1年的创伤性脊髓损伤参与者,评估疼痛干扰是否中介疼痛强度与可能重性抑郁(PMD)的关系。结果显示疼痛强度与PMD风险升高相关,但纳入疼痛干扰后该关系消失,提示疼痛干扰为中介变量;心理韧性为保护因素但非中介变量。

要点

  • 疼痛强度与PMD风险升高相关,但该关系由疼痛干扰完全中介。
  • 心理韧性在各模型中均对PMD具保护作用,但非中介变量。
  • 临床筛查PMD时应评估疼痛干扰,并针对降低疼痛干扰进行干预。

核心结论

  • 疼痛强度与PMD的关联由疼痛干扰中介,疼痛强度与PMD无直接关系。
  • 心理韧性是PMD的重要保护因素,但不是中介变量。

研究设计与样本

  • 横断面分析,采用自我报告评估,数据来自美国东南部一所医科大学。
  • 共纳入4670例病程至少1年的创伤性脊髓损伤参与者,来源于东南部区域SCI模型系统和两个州级监测系统。

主要发现

  • 疼痛强度与PMD风险升高相关:每日镇痛药使用者OR=1.28(95%CI 1.21-1.35),偶尔/每周使用者OR=1.26(95%CI 1.16-1.36),非镇痛药使用者OR=1.44(95%CI 1.33-1.56)。
  • 考虑疼痛干扰后,疼痛强度与PMD的关系消失:每日镇痛药使用者OR=0.97(95%CI 0.90-1.04),偶尔/每周使用者OR=0.94(95%CI 0.84-1.05),非镇痛药使用者OR=1.07(95%CI 0.95-1.20)。
  • 心理韧性在各模型中均对PMD具保护作用,但未显示中介效应。

关键数值与推荐

  • PMD采用患者健康问卷-9(PHQ-9)定义。
  • 按处方镇痛药使用频率分层(每日、偶尔/每周、无)分别进行多阶段logistic回归分析。

临床怎么用

  • 筛查PMD时应评估疼痛干扰,而不仅关注疼痛强度。
  • 治疗应针对降低疼痛干扰,并可通过提升心理韧性进一步降低PMD风险。

局限性

  • 横断面设计无法确立因果关系。
  • 研究基于自我报告评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether pain interference mediates the relationship between pain intensity and probable major depression (PMD) among persons with spinal cord injury (SCI), accounting for differences in the frequency of prescription medication use and resilience. DESIGN: Cross-sectional analysis using self-report assessment. SETTING: Medical university in the Southeastern United States. PARTICIPANTS: There were a total of 4670 participants (N=4670), all of whom had traumatic SCI of at least 1-year duration, identified from the Southeastern Regional SCI Model System and 2 state-based surveillance systems. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: The Patient Health Questionnaire-9 was used to define PMD. Covariates included demographic and injury characteristics, pain severity, pain interference, and resilience. Separate sets of multistage logistic regression analyses were conducted for 3 levels of prescription pain medication use (daily, occasional/weekly, none). RESULTS: Pain intensity was related to a greater risk of PMD (odds ratio [OR]daily pain medication user, 1.28; 95% confidence interval [CI], 1.21-1.35; ORoccasional/weekly pain medication user, 1.26; 95% CI, 1.16-1.36; ORnonpain medication user, 1.44; 95% CI, 1.33-1.56), but this relationship disappeared after consideration of pain interference (ORdaily pain medication user, 0.97; 95% CI, 0.90-1.04; ORoccasional/weekly pain medication user, 0.94; 95% CI, 0.84-1.05; ORnonpain medication user, 1.07; 95% CI, 0.95-1.20), which indicates pain interference was a mediator between pain intensity and PMD and there was no direct relationship between pain intensity and PMD. Resilience was protective of PMD in each model but was not a mediator. CONCLUSIONS: Although pain intensity was associated with PMD, the relationship was mediated by pain interference. Resilience was an important protective factor. Therefore, clinicians should assess pain interference when screening for PMD and direct treatment at reducing pain interference. Building resilience may further reduce the risk of PMD.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Li C, DiPiro ND, Clark JMR, et al. Mediating Effects of Pain Interference on the Relationships Between Pain Intensity and Probable Major Depression Among Participants With Spinal Cord Injury. Arch Phys Med Rehabil. 2021. PMID: 34015347. doi:10.1016/j.apmr.2021.04.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。